Back to Search

ANTHONY REDER, MD

MD

Neurology Physician

NPI: 1467503441IndividualAccepts Medicare

Specialties, Licenses & Credentials

Neurology PhysicianPrimary

Psychiatry & Neurology — Neurology

Code: 2084N0400X

CMS Specialties

PrimaryNEUROLOGY

Education

UNIVERSITY OF MICHIGAN MEDICAL SCHOOL

Class of 1978

Research & Publications (20)

IFN-beta1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression.
PMID 18547162·J Interferon Cytokine Res·2008
8-other
Recognizing and treating suboptimally controlled multiple sclerosis: steps toward regaining command.
PMID 19678753·Curr Med Res Opin·2009
6-review
Physiological proteomics and stress/starvation responses in Bacillus subtilis and Staphylococcus aureus.
PMID 19403106·Res Microbiol·2009
6-review
4-Aminopyridine toxicity mimics autoimmune-mediated limbic encephalitis.
PMID 19307545·Neurology·2009
5-case
Elevation of efficacy of cancer vaccine combined with interferon and inducer of endogeneous interferon synthesis amixin.
PMID 19112431·Exp Oncol·2008
7-preclinical
The Spx paralogue MgsR (YqgZ) controls a subregulon within the general stress response of Bacillus subtilis.
PMID 18643936·Mol Microbiol·2008
8-other
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.
PMID 18606968·Neurology·2008
6-review
Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis.
PMID 18573828·Mult Scler·2008
8-other
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
PMID 18525027·Neurology·2008
2-rct
IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions.
PMID 18279974·J Neuroimmunol·2008
4-observational
Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
PMID 17463069·Mult Scler·2007
8-other
Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
PMID 17389300·Neurology·2007
8-other
Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis.
PMID 16505297·Neurology·2006
4-observational
Therapeutic role of beta-interferons in multiple sclerosis.
PMID 16229894·Pharmacol Ther·2006
6-review
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.
PMID 15184588·Neurology·2004
7-preclinical
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.
PMID 15124756·Mult Scler·2004
8-other
Abnormal levels of interferon-gamma receptors in active multiple sclerosis are normalized by IFN-beta therapy: implications for control of apoptosis.
PMID 14977566·Front Biosci·2004
3-trial
Adeno-associated viral vector-mediated ApoE expression in Alzheimer's disease mice: low CNS immune response, long-term expression, and astrocyte specificity.
PMID 14977565·Front Biosci·2004
7-preclinical
Psychometric evaluation of the Chicago Multiscale Depression Inventory in multiple sclerosis patients.
PMID 12708812·Mult Scler·2003
8-other
Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.
PMID 12161037·J Neuroimmunol·2002
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
180 HARVESTER DR STE 110
BURR RIDGE, IL 60527

Location

Practice Location

180 HARVESTER DR STE 110, BURR RIDGE, IL
(773) 834-4064

Quick Facts

NPI
1467503441
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
48
Publications
20

Are you this provider?

Claim Your Profile